RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment

Hibah Aldawsari, Osama Ahmed, Nabil Alhakamy, Thikryat Neamatallah, Usama Fahmy, Shaimaa Badr-Eldin

Open source

DOI
10.3390/pharmaceutics13060783
Published
2021-05-24
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics13060783,
  title = {RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment},
  author = {Hibah Aldawsari and Osama Ahmed and Nabil Alhakamy and Thikryat Neamatallah and Usama Fahmy and Shaimaa Badr-Eldin},
  year = {2021},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics13060783},
  url = {https://doi.org/10.3390/pharmaceutics13060783}
}

RIS

TY  - JOUR
TI  - RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment
AU  - Hibah Aldawsari
AU  - Osama Ahmed
AU  - Nabil Alhakamy
AU  - Thikryat Neamatallah
AU  - Usama Fahmy
AU  - Shaimaa Badr-Eldin
PY  - 2021
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics13060783
UR  - https://doi.org/10.3390/pharmaceutics13060783
ER  - 

APA

Aldawsari, H., Ahmed, O., Alhakamy, N., Neamatallah, T., Fahmy, U., & Badr-Eldin, S. (2021). RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13060783

Source records